1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol has been researched along with Diabetes Mellitus, Type 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cani, PD; Delzenne, NM; Geurts, L; Muccioli, GG | 1 |
1 other study(ies) available for 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Chronic endocannabinoid system stimulation induces muscle macrophage and lipid accumulation in type 2 diabetic mice independently of metabolic endotoxaemia.
Topics: Animals; Cannabinoid Receptor Agonists; Diabetes Mellitus, Type 2; Dronabinol; Endocannabinoids; Endotoxemia; Macrophages; Male; Mice; Mice, Inbred C57BL | 2013 |